Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1391

1.

Treatment-free remission with first- and second-generation tyrosine kinase inhibitors.

Cortes J, Rea D, Lipton JH.

Am J Hematol. 2018 Nov 5. doi: 10.1002/ajh.25342. [Epub ahead of print] Review.

PMID:
30394563
2.

Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjögren's syndrome patients.

Cortés J, Hidalgo J, Aguilera S, Castro I, Brito M, Urra H, Pérez P, Barrera MJ, Carvajal P, Urzúa U, González S, Molina C, Bahamondes V, Hermoso M, González MJ.

J Autoimmun. 2018 Oct 31. pii: S0896-8411(18)30501-8. doi: 10.1016/j.jaut.2018.10.019. [Epub ahead of print]

PMID:
30391023
3.

Variable Neighborhood Search with Cost Function Networks To Solve Large Computational Protein Design Problems.

Charpentier A, Mignon D, Barbe S, Cortes J, Schiex T, Simonson T, Allouche D.

J Chem Inf Model. 2018 Nov 14. doi: 10.1021/acs.jcim.8b00510. [Epub ahead of print]

PMID:
30380857
4.

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.

Castroviejo-Bermejo M, Cruz C, Llop-Guevara A, Gutiérrez-Enríquez S, Ducy M, Ibrahim YH, Gris-Oliver A, Pellegrino B, Bruna A, Guzmán M, Rodríguez O, Grueso J, Bonache S, Moles-Fernández A, Villacampa G, Viaplana C, Gómez P, Vidal M, Peg V, Serres-Créixams X, Dellaire G, Simard J, Nuciforo P, Rubio IT, Dientsmann R, Barrett JC, Caldas C, Baselga J, Saura C, Cortés J, Déas O, Jonkers J, Masson JY, Cairo S, Judde JG, O'Connor MJ, Díez O, Balmaña J, Serra V.

EMBO Mol Med. 2018 Oct 30. pii: e9172. doi: 10.15252/emmm.201809172. [Epub ahead of print]

5.

Positive and negative religious coping as predictors of distress among minority older adults.

O'Brien B, Shrestha S, Stanley MA, Pargament KI, Cummings J, Kunik ME, Fletcher TL, Cortes J, Ramsey D, Amspoker AB.

Int J Geriatr Psychiatry. 2018 Oct 30. doi: 10.1002/gps.4983. [Epub ahead of print]

PMID:
30375027
6.

Nanocardboard as a nanoscale analog of hollow sandwich plates.

Lin C, Nicaise SM, Lilley DE, Cortes J, Jiao P, Singh J, Azadi M, Lopez GG, Metzler M, Purohit PK, Bargatin I.

Nat Commun. 2018 Oct 25;9(1):4442. doi: 10.1038/s41467-018-06818-6.

7.

Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.

Gabilondo I, Llorens V, Rodriguez T, Fernández M, Concha TP, Acera M, Tijero B, Murueta-Goyena A, Del Pino R, Cortés J, Gómez-Esteban JC.

Eur J Nucl Med Mol Imaging. 2018 Oct 15. doi: 10.1007/s00259-018-4183-0. [Epub ahead of print]

PMID:
30324423
8.

CXCR4 antagonists for treatment of breast cancer.

Cortés J, Holgado E, Perez-Garcia J.

Oncotarget. 2018 Sep 11;9(71):33442-33443. doi: 10.18632/oncotarget.26090. eCollection 2018 Sep 11. No abstract available.

9.

Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value.

Hidalgo-Lόpez JE, Kanagal-Shamanna R, Quesada AE, Gong Z, Wang W, Hu S, Medeiros LJ, Bassett RL Jr, d'Orcy E, Yin CC, Cortes J, Jabbour EJ, Kantarjian HM, Bueso-Ramos CE.

Cancer. 2018 Oct 1;124(19):3849-3855. doi: 10.1002/cncr.31663. Epub 2018 Oct 15.

PMID:
30321462
10.

Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage.

Jabbour E, Sasaki K, Ravandi F, Huang X, Short NJ, Khouri M, Kebriaei P, Burger J, Khoury J, Jorgensen J, Jain N, Konopleva M, Garcia-Manero G, Kadia T, Cortes J, Jacob J, Montalbano K, Garris R, O'Brien S, Kantarjian HM.

Cancer. 2018 Oct 15;124(20):4044-4055. doi: 10.1002/cncr.31720. Epub 2018 Oct 11.

PMID:
30307611
11.

Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.

Assi R, Garcia-Manero G, Ravandi F, Borthakur G, Daver NG, Jabbour E, Burger J, Estrov Z, Dinardo CD, Alvarado Y, Hendrickson S, Ferrajoli A, Wierda W, Cortes J, Kantarjian H, Kadia TM.

Cancer. 2018 Oct 11. doi: 10.1002/cncr.31658. [Epub ahead of print]

PMID:
30307606
12.

Exhaustive Exploration of the Conformational Landscape of Small Cyclic Peptides Using a Robotics Approach.

Jusot M, Stratmann D, Vaisset M, Chomilier J, Cortés J.

J Chem Inf Model. 2018 Oct 24. doi: 10.1021/acs.jcim.8b00375. [Epub ahead of print]

PMID:
30299093
13.

p95HER2-T cell bispecific antibody for breast cancer treatment.

Rius Ruiz I, Vicario R, Morancho B, Morales CB, Arenas EJ, Herter S, Freimoser-Grundschober A, Somandin J, Sam J, Ast O, Barriocanal ÁM, Luque A, Escorihuela M, Varela I, Cuartas I, Nuciforo P, Fasani R, Peg V, Rubio I, Cortés J, Serra V, Escriva-de-Romani S, Sperinde J, Chenna A, Huang W, Winslow J, Albanell J, Seoane J, Scaltriti M, Baselga J, Tabernero J, Umana P, Bacac M, Saura C, Klein C, Arribas J.

Sci Transl Med. 2018 Oct 3;10(461). pii: eaat1445. doi: 10.1126/scitranslmed.aat1445.

PMID:
30282693
14.

An efficient blue-white screening system for markerless deletions and stable integrations in Streptomyces chromosomes based on the blue pigment indigoidine biosynthetic gene bpsA.

Rezuchova B, Homerova D, Sevcikova B, Núñez LE, Novakova R, Feckova L, Skultety L, Cortés J, Kormanec J.

Appl Microbiol Biotechnol. 2018 Dec;102(23):10231-10244. doi: 10.1007/s00253-018-9393-7. Epub 2018 Sep 26.

PMID:
30259098
15.

Multiple modes of action of eribulin mesylate: Emerging data and clinical implications.

Cortes J, Schöffski P, Littlefield BA.

Cancer Treat Rev. 2018 Nov;70:190-198. doi: 10.1016/j.ctrv.2018.08.008. Epub 2018 Aug 21. Review.

16.

Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.

Campone M, Im SA, Iwata H, Clemons M, Ito Y, Awada A, Chia S, Jagiełło-Gruszfeld A, Pistilli B, Tseng LM, Hurvitz S, Masuda N, Cortés J, De Laurentiis M, Arteaga CL, Jiang Z, Jonat W, Le Mouhaër S, Sankaran B, Bourdeau L, El-Hashimy M, Sellami D, Baselga J.

Eur J Cancer. 2018 Nov;103:147-154. doi: 10.1016/j.ejca.2018.08.002. Epub 2018 Sep 18.

PMID:
30241001
17.

Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial.

Bardia A, Parton M, Kümmel S, Estévez LG, Huang CS, Cortés J, Ruiz-Borrego M, Telli ML, Martin-Martorell P, López R, Beck JT, Ismail-Khan R, Chen SC, Hurvitz SA, Mayer IA, Carreon D, Cameron S, Liao S, Baselga J, Kim SB.

J Clin Oncol. 2018 Sep 20:JCO2017748392. doi: 10.1200/JCO.2017.74.8392. [Epub ahead of print]

PMID:
30235087
18.

Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial.

Bixby D, Noppeney R, Lin TL, Cortes J, Krauter J, Yee K, Medeiros BC, Krämer A, Assouline S, Fiedler W, Dimier N, Simmons BP, Riehl T, Colburn D.

Br J Haematol. 2018 Sep 11. doi: 10.1111/bjh.15571. [Epub ahead of print] No abstract available.

PMID:
30203489
19.

Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.

Lewis TC, Cortes J, Altshuler D, Papadopoulos J.

J Intensive Care Med. 2018 Aug 30:885066618796486. doi: 10.1177/0885066618796486. [Epub ahead of print]

PMID:
30165770
20.

Acute respiratory syndrome following accidental inhalation of mercury vapor.

Cortes J, Peralta J, Díaz-Navarro R.

Clin Case Rep. 2018 Jun 21;6(8):1535-1537. doi: 10.1002/ccr3.1656. eCollection 2018 Aug.

Supplemental Content

Loading ...
Support Center